Universal health coverage could save $1T and 114k lives a year: study

Original Article ↗ Hacker News Discussion ↗

A Yale preprint claims that a single‑payer universal health care system in the U.S. could save about $1 trillion annually and prevent over 100,000 deaths, prompting scrutiny of its assumptions about lower drug prices, Medicare-level reimbursements, and reduced administrative waste and fraud. Commenters contrast these projected gains with likely trade‑offs: lower provider incomes, job losses in insurance and hospital administration, more explicit rationing of care, and higher taxes, while noting that Americans already pay far more for worse outcomes than other wealthy countries. Much of the debate centers on political feasibility—given entrenched industry interests, voter fear of disruption, and the mixed legacy of the Affordable Care Act—versus the potential economic and social benefits of decoupling health coverage from employment.

Study claims and methodological skepticism

  • Preprint estimates: single-payer UHC could save ~$1T/yr and ~114k lives by cutting drug prices, paying Medicare-like provider rates, reducing admin/fraud, and avoiding ER/hospital use via better primary care.
  • Several commenters say the modeling relies on optimistic assumptions (e.g., big provider cuts without collapse, less fraud, fewer avoidable ER visits despite a primary‑care shortage).
  • Others argue prior work by some authors has methodological issues and that effects disappear with corrections, but critics are pressed for concrete citations.
  • Mortality benefits are extrapolated from older observational data; some call that a weak basis.

Economic impacts and employment

  • Supporters: $1T “saved” becomes disposable income or investment; same national income is reallocated from insurers/shareholders to households and other sectors.
  • Critics: that $1T is someone’s income (administrators, hospitals, pharma, etc.); rapid cuts mean layoffs and local shocks in a sector that’s a top employer almost everywhere.
  • Some worry about GDP drop; others say this is broken-window thinking—wasteful healthcare jobs could be redeployed over time.

Government vs. private provision

  • Pro-UHC side: other developed countries show governments can buy care more cheaply with equal or better outcomes; public systems lack the profit-maximization incentives of private insurers.
  • Skeptics: government is also prone to perverse incentives, corruption, and slow feedback; point to the VA and some single‑payer systems with long waits and rationing.
  • Debate over whether admin savings are large (cutting “middlemen”) or modest once you net out remaining compliance/operations needs.

Quality, access, and rationing

  • Tradeoff debate: some highlight long waits and limited choice in UK/Canada; others counter that US also has long specialty waits and large numbers who delay or avoid care due to cost.
  • Rationing is seen as inevitable; disagreement is over whether it’s done via price and insurance denials (US) or queues and coverage rules (UHC).
  • US cancer survival is cited as strong, but critics note uninsured or underinsured patients often present late and fare worse.

Politics and feasibility

  • Broad agreement that entrenched interests (insurers, hospitals, pharma) and campaign finance are major obstacles.
  • Many argue voters with employer coverage fear disruption more than they value universality.
  • ACA is seen as an incremental, compromise step; some say it improved coverage and protections, others say it drove up premiums and was politically gutted.
  • Several conclude substantial reform is politically possible only via new coalitions or stepwise expansions (e.g., Medicare buy‑in), not an immediate full single‑payer shift.